The works cited page should be double-spaced throughout. The first line of each entry should be flush with the left margin; if the entry extends more than one line, ensuing lines should be indented 1/2 inch from the left margin.
The dose (volume of injection in mL) per month = patient weight (kg) x 15 mg per kg Ã· 100 mg per mL of Synagis. Injection volumes over 1 mL should be. given as a divided dose. â¢ Synagis is supplied as a single-dose vial and does not contain preservatives.
Reconstituted SynagisÂ® (palivizumab) is to be administered by intramuscular. injection only. Upon reconstitution, SynagisÂ® (palivizumab) contains the following excipients: 47. mM histidine, 3.0 mM glycine and 5.6% mannitol and the active ingredient, palivizumab, at a. concentration of 100 milligrams per mL solution.